Nothing to sniff at: Intranasal spray for dry eye

It’s not the first time the trigeminal nerve pathway or even intranasal delivery received approval as a treatment for dry eye, but clinicians are excited nonetheless about the October 2021 FDA approval of varenicline (TYRVAYA, Oyster Point Pharma), a nasal spray for the signs and symptoms of dry eye disease.

Comments Off on Nothing to sniff at: Intranasal spray for dry eye

ASCRS Director of Government Relations looks back on nearly 30-year career

Nancey McCann served as ASCRS director of Government Relations for 28 years. After retiring from the role at the end of March, Ms. McCann remains a consultant for ASCRS, working on several key initiatives. She reflected on some of the major issues ophthalmology and ASCRS faced during her career.

Comments Off on ASCRS Director of Government Relations looks back on nearly 30-year career